About IMCI Pharmaceuticals
Who We Are?
IMCI is a pharmaceutical company that develops cannabis-based medicines to treat neuropathic pain.
To assume its vision at an affordable price, IMCI operates a full value-chain of pharmaceutical cannabis-based production under SA & EU-GMP standards from seed to final product.
IMCI R&D is based in Israel while its operation locates in South Africa and target the African and the EU markets.
Full value chain from Seed to Final product
To become a leading pharmaceutical company in the African continent, who will develop pharmaceutical cannabis-based novel medicines and medical pharma-grade products to treat neuropathic pain in prevalent health conditions at an affordable price.